Epigenetic alterations in human liver from subjects with type 2 diabetes in parallel with reduced folate levels

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 11, 2015, Pages E1491-E1501

  Nilsson, Emma ^a   Matte, Ashok ^a,b   Perfilyev, Alexander ^a   De Mello, Vanessa D ^b   Käkelä, Pirjo ^c   Pihlajamäki, Jussi ^b,c   Ling, Charlotte ^a  

^a LUND UNIVERSITY DIABETES CENTRE   (Sweden)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; GROWTH FACTOR RECEPTOR BOUND PROTEIN 10; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; RNA H19;

ABCC3 GENE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; ERYTHROCYTE LEVEL; FEMALE; GENE; GENE EXPRESSION; GENOME IMPRINTING; GRB10 GENE; H19 GENE; HUMAN; HUMAN TISSUE; LIVER; LIVER BIOPSY; MALE; MOGAT1 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRDM16 GENE; PRIORITY JOURNAL; BIOPSY; BLOOD; BODY MASS; COHORT ANALYSIS; COMPLICATION; FINLAND; FOLIC ACID DEFICIENCY; GASTRIC BYPASS SURGERY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY, MORBID; PATHOLOGY;

ADULT; BIOPSY; BODY MASS INDEX; COHORT STUDIES; CPG ISLANDS; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FINLAND; FOLIC ACID; FOLIC ACID DEFICIENCY; GASTRIC BYPASS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIVER; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY, MORBID;

EID: 84958673442     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3204     Document Type: Article

References (61)

1. Groop L, Pociot F. Genetics of diabetes-are we missing the genes or the disease? Mol Cell Endocrinol. 2014;382:726-739.
2. Dayeh T, Volkov P, Salo S, et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and nondiabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 2014; 10:e1004160.
3. Nilsson E, Jansson PA, Perfilyev A, et al. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes. Diabetes. 2014;63:2962-2976.
4. Ribel-Madsen R, Fraga MF, Jacobsen S, et al. Genome-wide analysis ofDNAmethylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes. PLoS One. 2012;7:e51302.
5. Barres R, Osler ME, Yan J, et al. Non-CpG methylation of the PGC-1-promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009;10:189-198.
6. Volkmar M, Dedeurwaerder S, Cunha DA, et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 2012;31:1405-1426.
7. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr. 2012;3:21-38.
8. Horvath S, Erhart W, Brosch M, et al. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad Sci USA. 2014;111:15538-15543.
9. Pirola CJ, Gianotti TF, Burgueno AL, et al. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut. 2013;62:1356-1363.
10. Zhang H, Chu X, Huang Y, et al. Maternal vitamin D deficiency during pregnancy results in insulin resistance in rat offspring, which is associated with inflammation and I-b-methylation. Diabetologia. 2014;57:2165-2172.
11. Chang X, Yan H, Fei J, et al. Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. J Lipid Res. 2010;51:2504-2515.
12. Mannisto VT, Simonen M, Soininen P, et al. Lipoprotein subclass metabolism in nonalcoholic steatohepatitis. J Lipid Res. 2014;55: 2676-2684.
13. Pihlajamaki J, Gronlund S, SimonenM,et al. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding. Metabolism. 2010;59:866-872.
14. Pihlajamaki J, Kuulasmaa T, Kaminska D, et al. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. J Hepatol. 2012;56:663-670.
15. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
16. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.AmJ Gastroenterol. 1999;94:2467-2474.
17. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321.
18. BibikovaM,Barnes B, Tsan C, et al. High densityDNAmethylation array with singleCpGsite resolution. Genomics. 2011;98:288-295.
19. Chen YA, Lemire M, Choufani S, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium Human-Methylation450 microarray. Epigenetics. 2013;8:203-209.
20. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008;24:1547-1548.
21. Du P, Zhang X, Huang CC, et al. Comparison of α-value and Mvalue methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587.
22. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
23. Teschendorff AE, Marabita F, Lechner M, et al. A-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 kDNAmethylation data. Bioinformatics. 2013; 29:189-196.
24. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118-127.
25. Bertola A, Bonnafous S, Anty R, et al. Hepatic expression patterns of inflammatory andimmuneresponse genes associated with obesity and NASH in morbidly obese patients. PLoS One. 2010;5:e13577.
26. Fox J, Monette G. Generalized collinearity diagnostics. J Am Stat Assoc. 1992;87:178-183.
27. Broholm C, Brandt C, Schultz NS, Nielsen AR, Pedersen BK, Scheele C. Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes. Am J Physiol Endocrinol Metab. 2012;303:E283-E292.
28. Ferecatu I, Goncalves S, Golinelli-Cohen MP, et al. The diabetes drug target MitoNEET governs a novel trafficking pathway to rebuild an Fe-S cluster into cytosolic aconitase/iron regulatory protein 1. J Biol Chem. 2014;289:28070-28086.
29. Gupta RK, Gao N, Gorski RK, et al. Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α. Genes Dev. 2007;21:756-769.
30. Hayashi Y, Suemitsu E, Kajimoto K, et al. Hepatic monoacylglycerol O-acyltransferase 1 as a promising therapeutic target for steatosis, obesity, and type 2 diabetes. Mol Ther Nucleic Acids. 2014;3:e154.
31. Hurov JB, Huang M, White LS, et al. Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo. Proc Natl Acad Sci USA. 2007;104:5680-5685.
32. Imamura M, Maeda S, Yamauchi T, et al. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum Mol Genet. 2012;21:3042-3049.
33. Kim SJ, Chae S, Kim H, et al. A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus. Mol Cell Proteomics. 2014;13:811-822.
34. More VR, Wen X, Thomas PE, Aleksunes LM, Slitt AL. Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice. Comp Hepatol. 2012;11:1.
35. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981-990.
36. Ohno H, Shinoda K, Spiegelman BM, Kajimura S. PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab. 2012;15:395-404.
37. Piao G, Saito S, Sun Y, et al. A computational procedure for identifying master regulator candidates: a case study on diabetes progression in Goto-Kakizaki rats.BMCSyst Biol. 2012;6(suppl 1):S2.
38. Rampersaud E, Damcott CM, Fu M, et al. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetesrelated quantitative traits and from independent populations. Diabetes. 2007;56:3053-3062.
39. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-1801.
40. Skalniak L, Mizgalska D, Zarebski A, Wyrzykowska P, Koj A, Jura J. Regulatory feedback loop between NF-κB and MCP-1-induced protein 1 RNase. FEBS J. 2009;276:5892-5905.
41. Wang Q, Zhang X, Wang Y, Deng A, Zhu Z, Feng Y. Significance and expression of serum and glucocorticoid-inducible kinase in kidney of mice with diabetic nephropathy. J Huazhong Univ Sci Technolog Med Sci. 2005;25:170-173.
42. Xu Z, Lefevre GM, Felsenfeld G. Chromatin structure, epigenetic mechanisms and long-range interactions in the human insulin locus. Diabetes Obes Metab. 2012;14(suppl 3):1-11.
43. Zbidi H, Lopez JJ, Amor NB, Bartegi A, Salido GM, Rosado JA. Enhanced expression of STIM1/Orai1 and TRPC3 in platelets from patients with type 2 diabetes mellitus. Blood Cells Mol Dis. 2009; 43:211-213.
44. Ahrens M, Ammerpohl O, von Schonfels W, et al.DNAmethylation analysis in nonalcoholic fatty liver disease suggests distinct diseasespecific and remodeling signatures after bariatric surgery. Cell Metab. 2013;18:296-302.
45. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13:484-492.
46. da Costa AV, Calabria LK, de Souza Santos P, Goulart LR, Espindola FS. Glibenclamide treatment modulates the expression and localization of myosin-IIB in diabetic rat brain. J Neurol Sci. 2014; 340:159-164.
47. Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 2010;33:861-868.
48. Ge ZJ, Liang QX, Hou Y, et al. Maternal obesity and diabetes may cause DNA methylation alteration in the spermatozoa of offspring in mice. Reprod Biol Endocrinol. 2014;12:29.
49. Khan S, Raghuram GV, Bhargava A, et al. Role and clinical significance of lymphocyte mitochondrial dysfunction in type 2 diabetes mellitus. Transl Res. 2011;158:344-359.
50. Taneera J, Fadista J, Ahlqvist E, et al. Identification of novel genes for glucose metabolism based upon expression pattern in human islets and effect on insulin secretion and glycemia. Hum Mol Genet. 2015;24:1945-1955.
51. Zhou SS, Zhou YM, Li D, Lun YZ. Dietary methyl-consuming compounds and metabolic syndrome. Hypertens Res. 2011;34:1239-1245.
52. Mejos KK, Kim HW, Lim EM, Chang N. Effects of parental folate deficiency on the folate content, global DNA methylation, and expressions of FRα, IGF-2 and IGF-1R in the postnatal rat liver. Nutr Res Pract. 2013;7:281-286.
53. Akesson B, Fehling C, Jagerstad M, Stenram U. Effect of experimental folate deficiency on lipid metabolism in liver and brain. Br J Nutr. 1982;47:505-520.
54. Champier J, Claustrat F, Nazaret N, Fevre Montange M, Claustrat B. Folate depletion changes gene expression of fatty acid metabolism, DNA synthesis, and circadian cycle in male mice. Nutr Res. 2012;32:124-132.
55. McNeil CJ, Hay SM, Rucklidge GJ, et al. Disruption of lipid metabolism in the liver of the pregnant rat fed folate-deficient and methyl donor-deficient diets. Br J Nutr. 2008;99:262-271.
56. McNeil CJ, Hay SM, Rucklidge GJ, Reid MD, Duncan GJ, Rees WD. Maternal diets deficient in folic acid and related methyl donors modify mechanisms associated with lipid metabolism in the fetal liver of the rat. Br J Nutr. 2009;102:1445-1452.
57. Prokopenko I, Poon W, Magi R, et al. A central role for GRB10 in regulation of islet function in man.PLoSGenet. 2014;10:e1004235.
58. Nitert MD, Dayeh T, Volkov P, et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes. 2012;61:3322-3332.
59. Olsson AH, Volkov P, Bacos K, et al. Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets. PLoS Genet. 2014;10:e1004735.
60. Holt LJ, Siddle K. Grb10 and Grb14: enigmatic regulators of insulin action-and more? Biochem J. 2005;388:393-406.
61. Cowley M, Garfield AS, Madon-Simon M, et al. Developmental programming mediated by complementary roles of imprinted Grb10 in mother and pup. PLoS Biol. 2014;12:e1001799.